Physician
Cardiology
Dr. Steven G. Chrysant, MD
|
|
Give Review
Steven Chrysant is an expert in the field of Cardiology. He received awards:"Fellow (FACC)". Steven Chrysant is a published doctor. He has 100 papers published. The most current publication "Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasos..."
Publications
- The Cardiovascular Consequences of Excess Sitting Time.
- Dual Renin-Angiotensin-aldosterone blockade: promises and pitfalls.
- A Healthy Lifestyle Could Reduce the Onset of First Heart Attack by 80%
- Treatment of hypertension in patients with atherosclerotic renal artery stenosis, updated.
- Future of Polypill Use for the Prevention of Cardiovascular Disease and Strokes.
- Cardiovascular complications from consumption of high energy drinks: recent evidence.
- Controversy Regarding the Association of High Calcium Intake and Increased Risk for Cardiovascular Disease.
- Treatment of hypertension in patients with renal artery stenosis due to fibromuscular dysplasia of the renal arteries.
- The Age-Related Hemodynamic Changes of Blood Pressure and Their Impact on the Incidence of Cardiovascular Disease and Stroke: New Evidence.
- The current status of angioplasty of atherosclerotic renal artery stenosis for the treatment of hypertension.
- Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diab...
- Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension.
- An update on the cardiovascular pleiotropic effects of milk and milk products.
- New insights into the true nature of the obesity paradox and the lower cardiovascular risk.
- Olmesartan Medoxomil-Based Antihypertensive Therapy Evaluated by Ambulatory Blood Pressure Monitoring: Efficacy in High-Risk Patient Subgroups.
- The pleiotropic effects of phosphodiesterase 5 inhibitors on function and safety in patients with cardiovascular disease and hypertension.
- Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension: The TRINITY Randomized, Do...
- Blood pressure effects of high-dose amlodipine-benazepril combination in black and white hypertensive patients not controlled on monotherapy.
- The Role of Angiotensin II Receptors in Stroke Protection.
- Clinical Implications of Cardiovascular Preventing Pleiotropic Effects of Dipeptidyl Peptidase-4 Inhibitors.
- 24-Hour Efficacy and Safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: The TRINITY Ambulatory Blood Pressure Substudy.
- Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
- Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopul...
- Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.
- Blood pressure effects of naproxcinod in hypertensive patients.
- Current Status of Aggressive Blood Glucose and Blood Pressure Control in Diabetic Hypertensive Subjects.
- Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events.
- Current evidence on the hemodynamic and blood pressure effects of isometric exercise in normotensive and hypertensive persons.
- Current status of dual Renin Angiotensin aldosterone system blockade for the treatment of cardiovascular diseases.
- Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.
- Results of an olmesartan medoxomil-based treatment regimen in hypertensive patients.
- Proactive compared with passive adverse event recognition: calcium channel blocker-associated edema.
- Current and future status of beta-blockers in the treatment of hypertension.
- The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week facto...
- Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
- The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications.
- Niacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol.
- The pleiotropic effects of angiotensin receptor blockers.
- Pharmacological and clinical profile of moexipril: a concise review.
- Clinical experience with angiotensin receptor blockers with particular reference to valsartan.
- Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
- Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
- Has the role of calcium channel blockers in treating hypertension finally been defined?
- Perindopril/Hydrochlorothiazide Combination in Hypertensive Patients Unresponsive to Hydrochlorothiazide Alone: A Double-Blind, Multicenter Study.
- The TRINITY Study: distribution of systolic blood pressure reductions.
- Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension.
- Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study.
- Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerabil...
- Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.
- Treatment of white coat hypertension.
- Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studies.
- Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasos...
- Fixed low-dose drug combination for the treatment of hypertension.
- Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents ...
- Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hyp...
- Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertension. Long-term Use of Enalapril/Diltiazem ER in Stage 3-4 Hypertension Group.
- Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
- Evaluation of enalapril combined with diltiazem ER in patients with stage 3-4 essential hypertension.
- Vascular remodeling: the role of angiotensin-converting enzyme inhibitors.
- There are no racial, age, sex, or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patients.
- Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CD.
- Perindopril/hydrochlorothiazide dose combinations for the treatment of hypertension: a multicenter study.
- A comparison of the antihypertensive effectiveness of a combination of moexipril or sustained-release verapamil with low-dose hydrochlorothiazide.
- Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlle...
- Losartan potassium as initial therapy in patients with severe hypertension.
- Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension.
- Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. The Perindopril Study Group.
- Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
- Betaxolol in the treatment of stable angina pectoris.
- Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group.
- Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
- Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatm...
- Duration of effects of isradipine during twice daily therapy in angina pectoris.
- Effects of atenolol and diltiazem-SR on exercise and pressure load in hypertensive patients.
- Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension.
- Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable angina.
- Sustained blood pressure control with controlled-release isradipine.
- Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
- Sustained blood pressure control with controlled-release isradipine (isradipine-CR).
- Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response...
- Effects of diet on exaggerated natriuresis in hypertension.
- Effects of amiloride on arterial pressure and renal function.
- Renal functional and organic changes induced by salt and prostaglandin inhibition in spontaneously hypertensive rats.
- Hemodynamic correlates of autonomic reflexes in patients with labile and fixed hypertension.
- The mechanism for the renal hemodynamic and tubular action of furosemide.
- Hypomagnesemia and hypokalemia in 1,000 treated ambulatory hypertensive patients.
- The value of grip test as an index of autonomic function in hypertension.
- Long-term hemodynamic and metabolic effects of trimazosin in essential hypertension.
- Magnesium and potassium interrelationships, experimental and clinical.
- Antihypertensive and metabolic effects of hydrochlorothiazide, amiloride-hydrochlorothiazide, and timolol.
- Autonomic, systemic, and renal hemodynamic actions of trimazosin in hypertensive patients.
- Captopril stimulation of differential renins in renovascular hypertension.
- Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature.
- Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril.
- Systemic and renal hemodynamic effects of trimazosin: a new vasodilator.
- Evaluation of a new disposable dialyzer (Gambro).
- Factors influencing hematocrit response to testosterone in patients on chronic hemodialysis.
- Plasma renin activity in hypertension after renal homotransplantation.
- Side effects of antihypertensive drugs.
Doctors Specialties
- Internal Medicine
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
John H. Stroger Hospital of Cook County -
University of Athens
Helpful Reviews
Similar Doctors
|
|
Dr. Chittur A. Sivaram, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. William A. Collazo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sa D. Drooby, MD |
|
|
Dr. Jaspal S. Chawla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steve M. Blevins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Hoffman, MD |
|
|
Dr. Khadija H. Chaudrey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Terrance Khastgir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan W. Dennis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Warren M. Jackman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Siddharth A. Wayangankar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naji E. Karam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl J. Rubenstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Fors, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Koehler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Can Hasdemir, MD |